Investor Relations

Company Overview

Qualigen is a biotechnology company focused on the development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases, as well as expansion of its flagship FastPack® diagnostic platform. The FastPack® line of FDA-cleared and CE-Marked products has been used successfully in diagnostics since 2002. Our therapeutics pipeline includes cancer drug compounds such as QN-247 and RAS-F, as well as STARS, a DNA/RNA-based treatment device. By combining our demonstrated ability to quickly develop and commercialize innovative medical products with the advanced capabilities of leading cancer research centers, such as the University of Louisville, we are committed to providing exciting new therapeutic technologies to physicians and patients.

Stock Snapshot

Nasdaq: QLGN

Qualigen Therapeutics, Inc.

Latest Presentation

Latest News

Sign Up For Email Alerts

Receive updates straight into your inbox

Investor Contact Information

Company

Qualigen Therapeutics, Inc.
2042 Corte del Nogal
Suite B
Carlsbad, CA 92011
T: +760-918-9165
F: 760-918-9127
ir@qualigentx.com

Investor Relations

JQA Partners
Jules Abraham
T: +917-885-7378
jabraham@jqapartners.com

Transfer Agent

EQ Shareowner Services
PO Box 64874
St Paul, MN 55164
T: +8004689716
ShareownerOnline.com